BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30311421)

  • 1. Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer.
    Jung J; Suh YJ; Ko BK; Lee ES; Kim EK; Paik NS; Byun KD; Hwang KT
    Cancer Med; 2018 Nov; 7(11):5514-5524. PubMed ID: 30311421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
    Koh H; Maru N; Muramoto M; Wheeler TM; Scardino PT; Ohori M
    Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):595-601. PubMed ID: 12174634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Early-Stage Non-Small Cell Lung Cancer Patients with Different T2 Descriptors: Real Word Data From a Large Database.
    Cai JS; Wang X
    Lung; 2023 Aug; 201(4):415-423. PubMed ID: 37488303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.
    Cuffe S; Bourredjem A; Graziano S; Pignon JP; Domerg C; Ezzalfani M; Seymour L; Strevel E; Burkes R; Capelletti M; Jänne PA; Tsao MS; Shepherd FA
    J Thorac Oncol; 2012 Jun; 7(6):963-72. PubMed ID: 22588152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers.
    Alrawashdeh W; Kamarajah SK; Gujjuri RR; Cambridge WA; Shrikhande SV; Wei AC; Abu Hilal M; White SA; Pandanaboyana S
    HPB (Oxford); 2022 Jun; 24(6):789-796. PubMed ID: 35042673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
    Kawase A; Yoshida J; Miyaoka E; Asamura H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    J Thorac Oncol; 2013 May; 8(5):606-11. PubMed ID: 23478542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the Breast Cancer Staging System be Revised?
    Sanli AN; Tekcan Sanli DE; Aydogan F; Altundag MK
    Am Surg; 2024 May; 90(5):1066-1073. PubMed ID: 38128067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer.
    Bie F; Qu X; Yang X; Pang Z; Yang Y; Liu S; Dong W; Du J
    Sci Rep; 2017 Oct; 7(1):13050. PubMed ID: 29026165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
    van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
    BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unification of T2a and T2b tumors to T2 tumors in non-small cell lung cancer staging.
    Haraguchi S; Koizumi K; Akiyama H; Mikami I; Okada D; Yoshino N; Shimizu K
    Ann Thorac Cardiovasc Surg; 2011; 17(6):559-64. PubMed ID: 21881339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
    Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
    J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer.
    Ramos CG; Carvalhal GF; Smith DS; Mager DE; Catalona WJ
    J Urol; 1999 May; 161(5):1525-9. PubMed ID: 10210388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
    Han M; Walsh PC; Partin AW; Rodriguez R
    J Urol; 2000 Jul; 164(1):89-92. PubMed ID: 10840430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2,155): focus on the T category.
    Marchet A; Mocellin S; Ambrosi A; Morgagni P; Vittimberga G; Roviello F; Marrelli D; de Manzoni G; Minicozzi A; Coniglio A; Tiberio G; Pacelli F; Rosa F; Nitti D
    Eur J Surg Oncol; 2011 Sep; 37(9):779-85. PubMed ID: 21726975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Korea Tumor Registry System Biliary Pancreas (KOTUS-BP) Database Analysis.
    Lee SE; Choi YS; Kim YH; Heo JS; Jeong CY; Lee WJ; Seo HI; Yoon YS; Jang JY
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33053857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.